ASX Share rice
Sun 09 May 2021 - 06:20:pm (Sydney)

CPH Share Price

CRESO PHARMA LIMITEDCPHPharmaceuticals, Biotechnology & Life Sciences

CPH Company Information


Creso Pharma Limited




Drug Manufacturers-Specialty & Generic


145 Stirling Highway Nedlands WA Australia 6009


61 8 9389 3100

Co-Founder & Non-Exec. Chairman:

Mr. Adam Blumenthal B.Com., M.B.A.

Co-Founder & Non-Exec. Director:

Mr. Boaz Wachtel M.A., M.D., MBA

Chief Financial Officer:

Mr. Christopher Grundy

Exec. Director:

Dr. James Anthony Ellingford M.B.A., Ph.D., PG(Corp Mgmt), D.Mgt, MBA, AICD

Commercial & Marketing Director:

Dr. Gian Trepp

Joint Company Sec.:

Ms. Erlyn Saromines Dale A.C.I.S., B.Com., BCom., GradDipACG, AGIA, ACIS

Joint Company Sec.:

Mr. Winton William Willesee BBus, BBus., CPA, DipEd, DipEd., PGDipBus, PGDi


Dr. Simon H. W. Buckingham

Company Overview:

Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. The company develops and commercializes therapeutic products; and cultivates and harvests cannabis plants, as well as supplies dried cannabis plant retail products. Its products include anibidiol, a complementary feed product for companion animals; cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and zinc that reduces stress and supports psychological and nervous functions in humans; and topical and skin care products, which include cannaDOL, a CBD-based topical gel associated with a mixture of cooling and warming essential oils. The company also offers nutraceutical products, such as cannaQIX, a hemp oil-derived food supplement under the Cannamics brand. Creso Pharma Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.

CPH Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Revenue Per Share (TTM):


Earnings per Share:


Operating Margin (TTM):


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


CPH CashFlow Statement

CashFlow Date:




Change To Liabilities:


Total Cashflow From Investing Activities:


Net Borrowings:


Net Income:


Total Cash From Operating Activities:




Other Cashflow From Investing Activities:


Change To Inventory:


Change To Account Receivables:


Sale Purchase Of Stock:


Capital Expenditures:


CPH Income Statement

Income Date:


Income Before Tax:


Net Income:


Gross Profit:


Operating Income:


Other Operating Expenses:


Interest Expense:


Total Revenue:


Cost Of Revenue:


CPH Balance Sheet

Balance Sheet Date:


Intangible Assets:


Total Liabilities:


Total Stockholder Equity:


Other Current Liabilities:


Total Assets:


Common Stock:


Other Current Assets:


Retained Earnings:




Total Current Liabilities:


Short-Term Debt:


Property - Plant & Equipment:


Net Tangible Assets:


Total Current Assets:


Net Receivables:


Short-Term Investments:




Accounts Payable:


Short-Term Investments:


Non Current Liabilities Total:


CPH Share Price History

CPH News

12 Jan, 2021
SURREY, BC / ACCESSWIRE / January 12, 2021 / Gungnir Resources Inc. (TSXV:GUG)(OTCPK:ASWRF) ("Gungnir" or the "Company") is pleased to announce that the Company has received final approvals from Sweden's Inspector of Mines for new exploration permits which expand the size of the Knaften property by over 75%.
22 Dec, 2020
SURREY, BC / ACCESSWIRE / December 22, 2020 / Gungnir Resources Inc.
25 Nov, 2020
SURREY, BC / ACCESSWIRE / November 25, 2020 / Gungnir Resources Inc.
18 Nov, 2020
SURREY, BC / ACCESSWIRE / November 18, 2020 / Gungnir Resources Inc.
SURREY, BC / ACCESSWIRE / November 18, 2020 / Gungnir Resources Inc.
29 Oct, 2020
SURREY, BC / ACCESSWIRE / October 29, 2020 / Gungnir Resources Inc.